FDA & Government News
Why Scientists Are Revisiting a Polarizer
-
By
February 10, 2026
-
8 min
-
1
NCI studying ivermectin as cancer treatment.
-
2
Director Letai acknowledges public interest.
-
3
Concern over funding shifting from proven research.
-
4
Previous studies hint at anti-cancer potential but lack human evidence.
-
5
Misinformation on social media influences treatment choices.
-
6
Concerns about safety and patient risks if patients rely on ivermectin.
-
The National Cancer Institute (NCI) is investigating ivermectin as a potential cancer treatment due to increased public interest, despite the lack of new evidence supporting its effectiveness. NCI Director Anthony Letai acknowledged the drug's controversial status, particularly following its promotion during the COVID-19 pandemic. Some researchers express concern over diverting funds from established cancer research, arguing that misinformation surrounding ivermectin could lead patients to avoid effective treatments. Initial studies suggest potential anti-cancer properties, yet there is no conclusive evidence of its efficacy in humans.
-
1
NCI studying ivermectin as cancer treatment.
-
2
Director Letai acknowledges public interest.
-
3
Concern over funding shifting from proven research.
-
4
Previous studies hint at anti-cancer potential but lack human evidence.
-
5
Misinformation on social media influences treatment choices.
-
6
Concerns about safety and patient risks if patients rely on ivermectin.
Listen Tab content
